Biodistribution and Toxicity Studies of VSVG-Pseudotyped Lentiviral Vector after Intravenous Administration in Mice with the Observation of in Vivo Transduction of Bone Marrow
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 6 (1) , 19-29
- https://doi.org/10.1006/mthe.2002.0630
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Critical Factors Influencing Stable Transduction of Human CD34+ Cells with HIV-1-Derived Lentiviral VectorsMolecular Therapy, 2000
- Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectorsGene Therapy, 2000
- Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivoGene Therapy, 2000
- The Role of the Toxicologic Pathologist in the Preclinical Safety Evaluation of Biotechnology-Derived PharmaceuticalsToxicologic Pathology, 1999
- Real-Time Quantitative Polymerase Chain Reaction to Assess Gene TransferHuman Gene Therapy, 1999
- Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector systemGene Therapy, 1999
- Efficient Transduction of Human Lymphocytes and CD34+ Cells via Human Immunodeficiency Virus-Based Gene Transfer VectorsHuman Gene Therapy, 1999
- Preclinical Development Strategies for Novel Gene Therapeutic ProductsToxicologic Pathology, 1999
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- The glycoprotein G of rhabdovirusesArchiv für die gesamte Virusforschung, 1995